MoneyWorks4Me

Hikal - Quaterly Results

08 Aug 2023 Evaluate
The Total revenue for the quarter ended June 2023 of  Rs. 3880.50 millions remain, more or less, the same.The Total Profit for the quarter ended June 2023 of Rs. 68.60 millions grew from Rs.-89.40 millionsOperating profit surged to 511.70 millions from the corresponding previous quarter of 259.40 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 3880.50 3787.90 2.44 3880.50 3787.90 2.44 20230.30 19427.20 4.13
Other Income 9.40 32.70 -71.25 9.40 32.70 -71.25 54.10 48.90 10.63
PBIDT 511.70 259.40 97.26 511.70 259.40 97.26 2624.70 3454.50 -24.02
Interest 137.90 112.90 22.14 137.90 112.90 22.14 481.00 312.10 54.12
PBDT 373.80 146.50 155.15 373.80 146.50 155.15 2143.70 3142.40 -31.78
Depreciation 277.30 265.00 4.64 277.30 265.00 4.64 1090.10 956.70 13.94
PBT 96.50 -118.50 -181.43 96.50 -118.50 -181.43 1053.60 2185.70 -51.80
TAX 27.90 -29.10 -195.88 27.90 -29.10 -195.88 269.80 580.60 -53.53
Deferred Tax 0.70 -29.10 -102.41 0.70 -29.10 -102.41 -35.00 -15.90 120.13
PAT 68.60 -89.40 -176.73 68.60 -89.40 -176.73 783.80 1605.10 -51.17
Equity 246.60 246.60 0.00 246.60 246.60 0.00 246.60 246.60 0.00
PBIDTM(%) 13.19 6.85 92.56 13.19 6.85 92.56 12.97 17.78 -27.04
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..